Patents by Inventor Nikki L. PARKER

Nikki L. PARKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating cancer using combination therapies
    Patent number: 10010618
    Abstract: Described are methods, uses, and kits for utilizing a targeted ligand conjugate in combination with a thiol inhibitor or a system xc? inhibitor for the treatment of cancer or inflammation. Also described are in vitro assays utilizing a targeted ligand conjugate in combination with a thiol inhibitor or a system xc? inhibitor.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: July 3, 2018
    Assignee: Endocyte, Inc.
    Inventors: Nikki L. Parker, Christopher P. Leamon, Iontcho R. Vlahov
  • METHODS FOR TREATING CANCER USING COMBINATION THERAPIES
    Publication number: 20160296630
    Abstract: Described are methods, uses, and kits for utilizing a targeted ligand conjugate in combination with a thiol inhibitor or a system xc? inhibitor for the treatment of cancer or inflammation. Also described are in vitro assays utilizing a targeted ligand conjugate in combination with a thiol inhibitor or a system xc? inhibitor.
    Type: Application
    Filed: November 24, 2015
    Publication date: October 13, 2016
    Inventors: Nikki L. Parker, Christopher P. Leamon, Iontcho R. Vlahov
  • Methods For Treating Cancer Using Combination Therapies
    Publication number: 20140154702
    Abstract: Described are methods, uses, and kits for utilizing a targeted ligand conjugate in combination with a thiol inhibitor or a system xc? inhibitor for the treatment of cancer or inflammation. Also described are in vitro assays utilizing a targeted ligand conjugate in combination with a thiol inhibitor or a system xc? inhibitor.
    Type: Application
    Filed: March 14, 2013
    Publication date: June 5, 2014
    Inventors: Nikki L. PARKER, Christopher P. LEAMON, Iontcho R. VLAHOV